Cumberland Pharmaceuticals (CPIX) Reports Q1 Loss of $0.09

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q1 EPS of ($0.09), versus $0.02 reported last year. Revenue for the quarter came in at $8.6 million, versus $9.6 million reported last year.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• Endava CFO placed on leave amid accounting probe
• HP Inc. projects mid-single-digit PC market decline in 2027